Iradimed (IRMD) Receivables - Net (2013 - 2026)

Iradimed (IRMD) has 14 years of Receivables - Net data on file, last reported at $13.4 million in Q1 2026.

• On a quarterly basis, Receivables - Net rose 5.58% year-over-year to $13.4 million in Q1 2026; TTM through Mar 2026 was $13.4 million, a 5.58% increase from a year earlier, with the FY2025 full-year figure at $13.7 million, up 29.47% from the prior year.
• Receivables - Net for Q1 2026 stood at $13.4 million, down from $13.7 million in the prior quarter.
• Over the last five years, Receivables - Net for IRMD reached as high as $13.9 million in Q3 2025 and fell as low as $6.5 million in Q1 2022.
• Historically, Receivables - Net has averaged $11.6 million across 5 years, with a median of $12.0 million in 2024.
• Across the five-year window, Receivables - Net jumped 158.43% in 2022 and retreated 18.92% in 2024, its largest moves.
• Year by year, Receivables - Net stood at $13.3 million in 2022, then declined by 7.91% to $12.2 million in 2023, then decreased by 13.65% to $10.6 million in 2024, then increased by 29.47% to $13.7 million in 2025, then fell by 1.84% to $13.4 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $13.4 million in Q1 2026, $13.7 million in Q4 2025, and $13.9 million in Q3 2025.